Press Releases :: ContraFect Corporation (CFRX)

Press Releases

Investors & Media

ContraFect Awarded Funding from CARB-X to Support Gram-Negative Lysin Program

March 30, 2017

ContraFect Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Business Update

March 15, 2017

ContraFect Chairman and CEO Steven C. Gilman Takes Temporary Medical Leave

March 13, 2017

Lisa Ricciardi to Join Board of Directors

February 15, 2017

ContraFect Provides Program Update

January 6, 2017

ContraFect to Present at Biotech Showcase 2017 Conference

January 4, 2017

ContraFect to Present at 28th Annual Piper Jaffray Healthcare Conference

November 23, 2016

ContraFect Awarded $2.1 Million PRMRP Grant to Support Development of CF-301

November 17, 2016

ContraFect Announces Expanded Research Collaboration with The Rockefeller University to Identify Lysin Therapeutics Targeting Gram-negative Bacteria

November 14, 2016

ContraFect to Present at The Lysin Meeting

November 10, 2016